Metabolic Clearance Rate

"Metabolic Clearance Rate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site.

Descriptor ID	D008657
MeSH Number(s)	E01.370.225.843 E05.200.843 G03.490 G07.690.595 G07.690.725.513
Concept/Terms	Metabolic Clearance Rate Metabolic Clearance Rate Clearance Rate, Metabolic Clearance Rates, Metabolic Metabolic Clearance Rates Rate, Metabolic Clearance Rates, Metabolic Clearance Total Body Clearance Rate Total Body Clearance Rate

Below are MeSH descriptors whose meaning is more general than "Metabolic Clearance Rate".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Diagnosis [E01]
Diagnostic Techniques and Procedures [E01.370]
Clinical Laboratory Techniques [E01.370.225]
Metabolic Clearance Rate [E01.370.225.843]
Investigative Techniques [E05]
Clinical Laboratory Techniques [E05.200]
Metabolic Clearance Rate [E05.200.843]
Biological Sciences [G]
Metabolism [G03]
Metabolic Clearance Rate [G03.490]
Physiological Phenomena [G07]
Pharmacological and Toxicological Phenomena [G07.690]
Metabolic Clearance Rate [G07.690.595]
Pharmacokinetics [G07.690.725]
Metabolic Clearance Rate [G07.690.725.513]

Below are MeSH descriptors whose meaning is related to "Metabolic Clearance Rate".

Below are MeSH descriptors whose meaning is more specific than "Metabolic Clearance Rate".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Metabolic Clearance Rate" by people in this website by year, and whether "Metabolic Clearance Rate" was a major or minor topic of these publications.

Bar chart showing 15 publications over 11 distinct years, with a maximum of 2 publications in 1992 and 2002 and 2003 and 2005

To see the data from this visualization as text, click here.

Year	Minor Topic	Total
1992	2	2
1996	1	1
1997	1	1
2001	1	1
2002	2	2
2003	2	2
2005	2	2
2006	1	1
2014	1	1
2015	1	1
2019	1	1

Below are the most recent publications written about "Metabolic Clearance Rate" by people in Profiles.

Lim SY, Woo S, Miller JL, Skrepnek GH, Henry ED, Johnson PN. Prediction and Comparison of Fentanyl Infusion Pharmacokinetics in Obese and Nonobese Children. Pediatr Crit Care Med. 2019 12; 20(12):e556-e564.

View in: PubMed
Stohl W, Merrill JT, Looney RJ, Buyon J, Wallace DJ, Weisman MH, Ginzler EM, Cooke B, Holloway D, Kaliyaperumal A, Kuchimanchi KR, Cheah TC, Rasmussen E, Ferbas J, Belouski SS, Tsuji W, Zack DJ. Treatment of systemic lupus erythematosus patients with the BAFF antagonist "peptibody" blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b trials. Arthritis Res Ther. 2015 Aug 20; 17:215.

View in: PubMed
Thompson P, Wheeler HE, Delaney SM, Lorier R, Broeckel U, Devidas M, Reaman GH, Scorsone K, Sung L, Dolan ME, Berg SL. Pharmacokinetics and pharmacogenomics of daunorubicin in children: a report from the Children's Oncology Group. Cancer Chemother Pharmacol. 2014 Oct; 74(4):831-8.

View in: PubMed
Yeh AT, Hirshburg J. Molecular interactions of exogenous chemical agents with collagen--implications for tissue optical clearing. J Biomed Opt. 2006 Jan-Feb; 11(1):014003.

View in: PubMed
Sainathan SK, Tu L, Bishnupuri KS, Han M, Li A, Newberry RD, McDonald KG, Crimmins DL, Houchen C, Anant S, Dieckgraefe BK. PEGylated murine Granulocyte-macrophage colony-stimulating factor: production, purification, and characterization. Protein Expr Purif. 2005 Dec; 44(2):94-103.

View in: PubMed
Sharpe AL, Coste SC, Burkhart-Kasch S, Li N, Stenzel-Poore MP, Phillips TJ. Mice deficient in corticotropin-releasing factor receptor type 2 exhibit normal ethanol-associated behaviors. Alcohol Clin Exp Res. 2005 Sep; 29(9):1601-9.

View in: PubMed
Smith CJ, Gali H, Sieckman GL, Hayes DL, Owen NK, Mazuru DG, Volkert WA, Hoffman TJ. Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells. Nucl Med Biol. 2003 Feb; 30(2):101-9.

View in: PubMed
Awasthi V, Goins B, McManus L, Klipper R, Phillipsa WT. [99mTc] liposomes for localizing experimental colitis in a rabbit model. Nucl Med Biol. 2003 Feb; 30(2):159-68.

View in: PubMed
Gaston RC, Arnold CD, Ahluwalia BD, Sonnad JR, Macdurmon GW, Gold MA, Parry CK, Montebello JF, Mayr NA. Pitfalls of radiation survey after brachytherapy implant removal preceding Tl-201 study. Clin Nucl Med. 2002 Jul; 27(7):494-8.

View in: PubMed
Kostis JB, Dockens RC, Thadani U, Bethala V, Pepine C, Leimbach W, Vachharajani N, Raymond RH, Stouffer BC, Tay LK, Shyu WC, Liao WC. Comparison of pharmacokinetics of lanoteplase and alteplase during acute myocardial infarction. Clin Pharmacokinet. 2002; 41(6):445-52.

View in: PubMed

People

Explore

Similar Concepts

Top Journals